KRP-116D ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
226Interstitial cystitis with Hunners ulcer1

226. Interstitial cystitis with Hunners ulcer


Clinical trials : 145 Drugs : 156 - (DrugBank : 51) / Drug target genes : 64 - Drug target pathways : 146
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-173566
25/5/201720/04/2017Phase III study of KRP-116DA Phase III, multicenter, randomized, double-blind, placebo controlled, parallel group study to assess the efficacy and safety of KRP-116D in Japanese patients with interstitial cystisis. Interstitial cystitis( IC )Intervention name : KRP-116D
INN of the intervention : dimethyl sulfoxide
Dosage And administration of the intervention : 50 mL intravesical instillation once every two weeks
Control intervention name : Placebo
INN of the control intervention : -
Dosage And administration of the control intervention : 50 mL intravesical instillation once every two weeks
Kyorin Pharmaceutical Co.,LTDNULLcomplete20BOTH90Phase 3Japan